| Addictions | Bipolar | Depression | Eating Disorders | Genetic | Personality Disoder | Learning Disabilities |
| Psychological Distress | Psychosis | Schizophrenia | Unexplained Symptoms | Aspergers Syndrome | Autism | Other |
| fNEMO Neuropsychological function as a result of chronic exposure to methadone and other opiates (NEMO): neural responses to rewards - a study using functional magnetic resonance imaging (fMRI) | Chief Investigator Dr Alex Baldacchino |
| A clinical, neuropsychological and magnetic resonance imaging study comparing autism spectrum disorders and schizophrenia spectrum disorders A clinical, neuropsychological and magnetic resonance imaging study comparing autism spectrum disorders and schizophrenia spectrum disorders | Chief Investigator Dr Andrew Stanfield |
| Efficacy of a group based social skills intervention in adults with Asperger syndrome Efficacy of a group based social skills intervention in adults with Asperger syndrome | Chief Investigator Dr Andrew Stanfield |
| CEQUEL Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression. | Chief Investigator Professor John Geddes |
| BFS Bipolar Family Study | Chief Investigator Dr Andrew McIntosh |
| Molecular Study Molecular Genetic Investigation of Bipolar Disorder and Related Mood Disorder | Chief Investigator Professor Nick Craddock |
| Emotional processing in Bipolar Disorder Emotional processing in Bipolar Disorder | Chief Investigator Dr Jess Sussmann |
| A pilot randomised controlled trial of Cognitive Behaviour Therapy for early bipolar disorder. A pilot randomised controlled trial of Cognitive Behaviour Therapy for early bipolar disorder. | Chief Investigator Dr Jamie Kirk |
| ProCEED Evaluation of a system of structured, pro-active care for chronic depression in primary care | Chief Investigator Dr Marta Buszewicz |
| SMaRT Oncology-2 Trial Symptom Management Research Trials - SMaRT Oncology-2 Trial | Chief Investigator Professor Michael Sharpe |
| SMaRT Oncology-3 Pilot Symptom Management Research Trials - SMaRT Oncology-3 Pilot | Chief Investigator Professor Michael Sharpe |
| SMaRT Oncology-3 Trial Symptom Management Research Trials - SMaRT Oncology-3 Trial | Chief Investigator Professor Michael Sharpe |
| GCIT Evaluation of cognitive interpersonal group Evaluation of cognitive interpersonal group therapy for psychosis | Chief Investigator Dr Christine Braehler |
| Diffusion Tensor and Functional Imaging of Chronic Treatment Refractory Depression and Neurosurgical Treatments DTFI | Chief Investigator Prof Douglas Steele |
| COBALT Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: a randomised controlled trial | Chief Investigator Dr Nicola Wiles |
| DBS A clinical evaluation for the management of patients with Major Depressive Disorder, single or recurrent episode, with deep brain stimulation. | Chief Investigator Professor Keith Matthews |
| SPECT The effects of TNF blockade (using etanercept) on substrates of mood and cognition in patients with inflammatory arthritis. | Chief Investigator Dr Jonathan Cavanagh |
| ISA Inflammatory Bowel Disease, Steroids and Affective Disorder | Chief Investigator Dr Benjamin Baig |
| CBASP Intensive psychotherapy for chronic, treatment-resistant depression: a pilot investigation of clinical effectiveness and mediators of learning in the Cognitive Behavioural Analysis System of Psychotherapy (CBASP) | Chief Investigator John Swan |
| KANECT The use of Ketamine as an anaesthetic during electroconvulsive therapy (ECT) for depression: does it improve treatment outcome? | Chief Investigator Professor Ian Reid |
| ASPEN Anti-Stigma Partnership European Network | Chief Investigator Professor Graham Thornicroft |
| iMANTRA-R Internet-based relapse prevention for in-patients with Anorexia Nervosa | Chief Investigator Professor Ulrike Schmidt |
| Scottish Family Genetic Colloboration Scottish Family Genetic Collaboration | Chief Investigator Dr Andrew McIntosh |
| GS SFHS Generation Scotland: Scottish Family Health Study | Chief Investigator Professor Andrew Morris |
| DownsLit Genetically determined brain abnormalities in Down’s syndrome – towards a treatment | Chief Investigator Professor Declan Murphy |
| A multi-centre phase 3 Cluster randomized controlled trial of a manualized anger management intervention for people with mild to moderate learning disabilities A multi-centre phase 3 Cluster randomized controlled trial of a manualized anger management intervention for people with mild to moderate learning disabilities | Chief Investigator Professor Paul Willner |
| NOVARTIS A randomised, double blind, placebo-controlled, parallel group study to evaluate AFQ056 in adult patients with Fragile X Syndrome | Chief Investigator Dr Andrew Stanfield |
| A Neuropsychological Study of Emotion Regulation and Impulsivity A Neuropsychological Study of Emotion Regulation and Impulsivity | Chief Investigator Dr Jeremy Hall |
| ENGAGE Meeting mental health needs of complex co-morbid patients following a suicide attempt. A pilot study. | Chief Investigator Prof Kate Davidson |
| PODS Persistence of distress in cancer outpatients: a symptom follow-up study | Chief Investigator Prof Michael Sharpe |
| EDIE 2 Early Detection and Intervention Evaluation for individuals at high risk of psychosis (2) | Chief Investigator Dr Anthony Morrison |
| PACT Acceptance and Commitment Therapy for Psychosis | Chief Investigator Dr Ross White |
| Scottish Family Mental Health Study Brain imaging studies of pre-frontal glutamate concentration, perfusion and activity. | Chief Investigator Prof Stephen Lawrie |
| LD Rescan Further studies of mental health in young people with additional learning needs. | Chief Investigator Prof David Owens |
| Trust in Schizophrenia investigated with an Economics Game Paradigm Trust in Schizophrenia investigated with an Economics Game Paradigm | Chief Investigator Dr James Currie |
| A single sequence, open-label, methodology study to assess cognitive change in patients with schizophrenia after supervised training with the Brain Fitness Program A single sequence, open-label, methodology study to assess cognitive change in patients with schizophrenia after supervised training with the Brain Fitness Program | Chief Investigator |
| The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms | Chief Investigator Professor Bill Deakin |
| Roche negative Study to evaluate efficacy and safety of RO4917838 in stable patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics followed by a 28 week, doubleblind treatment period | Chief Investigator Professor John Geddes |
| Roche sub-optimal Study to evaluate the efficacy and safety of RO4917838 in patients with sub-optimally controlled symptoms of schizophrenia treated with antipsychotics followed by a 40-week double-blind, parallel group, placebo-controlled treatment period. | Chief Investigator Professor John Geddes |
| MSS Multiple Symptom Study | Chief Investigator Dr Chris Burton |





